Literature DB >> 12678879

Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations.

William A Banks1.   

Abstract

Leptin has emerged as a major regulator of body adiposity. The majority of humans with obesity have a resistance to leptin. Human and rodent studies indicate that the major cause of this resistance arises from an impaired ability of leptin to cross the blood-brain barrier, with lesser roles played by receptor and post-receptor defects. Evidence from baboons living in the wild is consistent with the hypothesis that during most of evolution serum levels of leptin were much lower than those currently considered normal. Leptin may have evolved to signal to the brain when caloric reserves were adequate to engage in reproductive and other behaviors not immediately concerned with acquisition of calories. The leptin transporter is a regulated system, with the rate of transport being increased by alpha(1) adrenergic agents and decreased by starvation. Impaired regulation of the transporter or impairments in transporter production could underlie the resistance caused by transporter defects. Evolutionary pressures would not have selected against such impairments if leptin levels were lower than those typically seen in Western society. A model that could explain how leptin transporter resistance can be acquired is presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678879     DOI: 10.2174/1381612033455350

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  23 in total

Review 1.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

2.  Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells.

Authors:  Kalyan Reddy Manda; Atrayee Banerjee; William A Banks; Nuran Ercal
Journal:  Free Radic Biol Med       Date:  2010-12-28       Impact factor: 7.376

Review 3.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

4.  Early postweaning exercise improves central leptin sensitivity in offspring of rat dams fed high-fat diet during pregnancy and lactation.

Authors:  Bo Sun; Nu-Chu Liang; Erin R Ewald; Ryan H Purcell; Gretha J Boersma; Jianqun Yan; Timothy H Moran; Kellie L K Tamashiro
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-11       Impact factor: 3.619

Review 5.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

6.  Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells.

Authors:  Hung Hsuchou; Abba J Kastin; Hong Tu; N Joan Abbott; Pierre-Olivier Couraud; Weihong Pan
Journal:  J Neurochem       Date:  2010-10-26       Impact factor: 5.372

Review 7.  The blood-brain barrier: connecting the gut and the brain.

Authors:  William A Banks
Journal:  Regul Pept       Date:  2008-04-07

8.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

9.  Urocortin trafficking in cerebral microvessel endothelial cells.

Authors:  Hong Tu; Abba J Kastin; Christian Bjorbaek; Weihong Pan
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

10.  Obesity induces functional astrocytic leptin receptors in hypothalamus.

Authors:  Hung Hsuchou; Yi He; Abba J Kastin; Hong Tu; Emily N Markadakis; Richard C Rogers; Paul B Fossier; Weihong Pan
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.